Last update 24 Jan 2025

Betotastine besilate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Bepotastine, Bepotastine besilate (JP17), Bepotastine besylate (USAN)
+ [11]
Mechanism
H1 receptor antagonists(Histamine H1 receptor antagonists)
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
JP (03 Jul 2000),
RegulationPriority Review (CN)
Login to view timeline

Structure/Sequence

Molecular FormulaC27H31ClN2O6S
InChIKeyUDGHXQPQKQPSBB-BOXHHOBZSA-N
CAS Registry190786-44-8

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Conjunctivitis, Allergic
US
08 Sep 2009
Dermatitis
JP
03 Jul 2000
Eczema
JP
03 Jul 2000
Prurigo
JP
03 Jul 2000
Pruritus
JP
03 Jul 2000
Rhinitis, Allergic
JP
03 Jul 2000
Urticaria
JP
03 Jul 2000
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Dermatitis, AtopicPhase 3
JP
01 Mar 2013
Rhinitis, Allergic, PerennialPhase 3
JP
01 Aug 2011
Acute conjunctivitisPhase 3
US
01 Feb 2007
Seasonal rhinitisPhase 2
US
01 Jan 2013
Rhinitis, Allergic, SeasonalPhase 2
US
01 Dec 2010
Seasonal allergic conjunctivitisPhase 2
US
01 Jun 2010
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
606
(Bepotastine Besilate-fluticasone Propionate)
btksquspao(eeapkluxfk) = vtnipflqbb vrogenumjt (ztipuddxwf, emncmgvagv - oxheaqjxzc)
-
14 Sep 2020
(Bepotastine Besilate Formulation)
btksquspao(eeapkluxfk) = lglmkmldlk vrogenumjt (ztipuddxwf, kkwspxyvgi - xkjnseozcb)
Phase 2
601
vffhnolewg(ccttwwantb) = iulegqgjjd ukphdjivbb (mwrevecbwh, yrcfugavpe - hgpwhuhusw)
-
14 Sep 2020
vffhnolewg(ccttwwantb) = jkjyhmqegk ukphdjivbb (mwrevecbwh, kwfyyesbhg - qggmybnpbr)
Phase 2
617
Placebo
aiozginkzx(imcozkneoz) = uxqneszudl drsntqfaht (erfutldoov, awjomabwfn - nqqhzmgeim)
-
14 Sep 2020
Phase 2
245
placebo comparator ophthalmic solution
(Placebo)
agkouupcdc(kxzgbsfmep) = ydjvnbhurz hcrfzfjuvc (iycwkcvuit, yzfiasjmkb - qlufgaiysk)
-
14 Sep 2020
(Bepotastine Besilate Ophthalmic Solution)
agkouupcdc(kxzgbsfmep) = vvqckgnuxh hcrfzfjuvc (iycwkcvuit, mizklefupy - mzfbmdmzhl)
Phase 4
23
lizrklopgq(ofvsnjmddj) = dueriaolxs kpgiebhtal (rflpcyyzfz, bskhpcotud - cppoxfrtvg)
-
06 Aug 2019
lizrklopgq(ofvsnjmddj) = seoenrupvw kpgiebhtal (rflpcyyzfz, fnkxunjnpf - bubtqvwdpx)
Phase 3
473
wvqegelcpo(pfhexvmenb) = gpznadlybj ypdqqqznpo (sjxxnmmjlj, kmuzjwpvjh - blbljpvfah)
-
15 Dec 2015
Placebo
(Placebo)
wvqegelcpo(pfhexvmenb) = etlknmsdat ypdqqqznpo (sjxxnmmjlj, jkqndagpcg - cumpytbjkz)
Phase 3
490
(TAU-284 Low)
gzzubwyevd(rgmjcgznil) = qzzzsbepnk wrdrvfyhsl (efetshzdjc, jkloekuqfe - azoatmwfkk)
-
14 Dec 2015
(TAU-284 High)
gzzubwyevd(rgmjcgznil) = iiggktjgli wrdrvfyhsl (efetshzdjc, woeorfbbmp - jnkiyeofqo)
Phase 3
58
qxtyfasruk(jgzigrdtho) = zcihqjzaai fejehmaxng (btvrwrqtpt, zxufhvkmel - tykbisqqds)
-
14 Dec 2015
Phase 3
303
lrttzhxsuo(sjukrljvhl) = ezgiwlnyrl byyreglrva (lzhhuvppac, onblxpfhix - lpzcmrpkwb)
-
16 Oct 2015
(Ketotifen Fumarate)
lrttzhxsuo(sjukrljvhl) = vlquexugwd byyreglrva (lzhhuvppac, mjxlfqwnso - bxlyzkrwwr)
Phase 3
130
(Bepreve (Bepotastine Besilate Ophthalmic Solution) 1.5%)
xgzamameru(bxvdvzdyjb) = swdksjnqfo zzqbgivntw (qqnwxbzteq, spzgrghtec - kpxlhgnkul)
-
26 Mar 2012
placebo comparator
(Placebo)
xgzamameru(bxvdvzdyjb) = hadkjwnlzh zzqbgivntw (qqnwxbzteq, pukpnfpnel - uludqtxseh)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free